Your browser doesn't support javascript.
loading
[Cardiometabolic risk in patients with primary aldosteronism and autonomous cortisol secretion. Case-control study]. / Riesgo cardiometabólico en pacientes con hiperaldosteronismo primario y secreción autónoma de cortisol. Estudio de casos y controles.
Araujo-Castro, Marta; Bengoa Rojano, Nuria; Fernández Argüeso, María; Pascual-Corrales, Eider; Jiménez Mendiguchía, Lucía; García Cano, Ana M.
Afiliación
  • Araujo-Castro M; Servicio de Endocrinología y Nutrición. Hospital Universitario Ramón y Cajal, Madrid, España; Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, España. Electronic address: marta.araujo@salud.madrid.org.
  • Bengoa Rojano N; Servicio de Endocrinología y Nutrición. Hospital Universitario Ramón y Cajal, Madrid, España.
  • Fernández Argüeso M; Servicio de Endocrinología y Nutrición. Hospital Universitario Ramón y Cajal, Madrid, España.
  • Pascual-Corrales E; Servicio de Endocrinología y Nutrición. Hospital Universitario Ramón y Cajal, Madrid, España.
  • Jiménez Mendiguchía L; Servicio de Bioquímica. Hospital Universitario Ramón y Cajal, Madrid, España.
  • García Cano AM; Servicio de Bioquímica. Hospital Universitario Ramón y Cajal, Madrid, España.
Med Clin (Barc) ; 157(10): 473-479, 2021 11 26.
Article en En, Es | MEDLINE | ID: mdl-33039136
OBJECTIVE: To analyse the differences in the cardio-metabolic profile of patients with primary aldosteronism (PA) and autonomous cortisol secretion (ACS) matched by age and sex. METHODS: Case-control study; cases of PA without associated ACS and as controls patients with ACS (dexamethasone suppression test ≥ 1.8 µg/dL in the absence of specific hypercortisolism clinical data), matched by age and sex. Comorbidities of hypertension, diabetes, obesity, dyslipidaemia, chronic kidney failure, and cardiovascular and cerebrovascular events were analysed, as well as their degree of control. RESULTS: 57 patients with PA and 57 with ACS were included. On diagnosis, in addition to a higher prevalence of hypertension in the PA patients (100 vs. 52.7%, p < .0001) and higher systolic blood pressure levels (143.2 (2.5) vs. 135.3 (2.6) mmHg, p = .032) than in the ACS patients, no other differences were detected in the prevalence of other cardio-metabolic comorbidities. Nevertheless, the patients with ACS had higher HbA1c levels (p = .028) than the PA patients. After a median follow-up of 2.25 years, the patients with PA presented a greater deterioration in kidney function (Average decrease in glomerular filtration rate (MDRD-4) -17.4 (3.0) vs. -2.3 (4.4) mL/min/1.73 m2, p = .005) and lipid profile (Δtriglycerides of 34.5 (15.8) vs. -6.7 (11.3) mg/dL, p = .038) than the ACS patients. CONCLUSIONS: Despite the higher prevalence of hypertension in the patients with PA than in the patients with ACS matched by age and sex, no differences were detected in the prevalence of other cardio-metabolic comorbidities. However, the PA patients showed a greater deterioration in kidney function and lipid profile throughout the follow-up than the ACS patients.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperaldosteronismo / Hipertensión Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies Límite: Humans Idioma: En / Es Revista: Med Clin (Barc) Año: 2021 Tipo del documento: Article Pais de publicación: España

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Hiperaldosteronismo / Hipertensión Tipo de estudio: Diagnostic_studies / Etiology_studies / Observational_studies / Prevalence_studies Límite: Humans Idioma: En / Es Revista: Med Clin (Barc) Año: 2021 Tipo del documento: Article Pais de publicación: España